BVF »

Aeglea Biotherapeutics shares owned by BVF

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by BVF from 13F filings

Historical chart of BVF investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by BVF consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by BVF

Quarter filed Position value Share count Share price at filing
2023-12-31 $15M 687k 21.52

More positions owned by BVF

Moonlake Immunotherapeutics Class A Ord (MLTX)
Revolution Medicines (RVMD)
Axsome Therapeutics (AXSM)
Protagonist Therapeutics (PTGX)
Kymera Therapeutics (KYMR)
Mirum Pharmaceuticals (MIRM)
Olema Pharmaceuticals (OLMA)
Ionis Pharmaceuticals (IONS)
Kura Oncology (KURA)
4d Molecular Therapeutics In (FDMT)
Galapagos Nv Spon Adr (GLPG)
Merus N V (MRUS)
Repare Therapeutics Ord (RPTX)
Ac Immune Sa SHS (ACIU)
Centessa Pharmaceuticals Sponsored Ads (CNTA)

View all positions for BVF

Top funds holding Aeglea Biotherapeutics

Perceptive Advisors
VR Adviser
Commodore Capital
venBio Select Advisor
Cormorant Asset Management
EcoR1 Capital
Franklin Resources
BVF
Wellington Management Company
Citadel Advisors
Braidwell
Global Endowment Management
Fairmount Funds Management
Boxer Capital
Logos Global Management

View all funds holding Aeglea Biotherapeutics